According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

When people high in narcissism feel slighted or criticized, it threatens their fragile or inflated self-esteem, prompting ...

Nuvalent is approaching the precipice of a first targeted therapy approval in lung cancer. Click here to read why NUVL stock ...

Compassus Health and Hospice Care consultant Kathy Rackers gave insight into end-of-life care to the Callaway Resource ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...

Chaos unfolded at Cooper Hospital following the death of a patient, as the medical staff faced aggression from the deceased's ...

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast ...

Diverticulitis, once a concern for older adults, is now increasingly affecting Americans under 50. Hospitalizations for ...